Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the co

• 作 者: Joshua C Berkowitz Joanna Stei
• 机 构: DepartmentofMedicine,FeinsteinInstituteforMedicalResearch,DepartmentofMedicine,DepartmentofMedicine
• 出 处: 世界胃肠药理与治疗学杂志：英文版（电子版）
• 发表日期: 2018年1期
• 关键词: Crohn’s DISEASE ULCERATIVE colitis INFLIXIMAB AZATHIOPRINE Inflammatory bowel DI

AIM To describe trends of combination therapy(CT)of infliximab(IFX)and immunomodulator(IMM)for inflammatory bowel disease(IBD)in the community setting.METHODS A retrospective study was conducted of all IBD patients referred for IFX infusion to our communi